YKR045C Antibody

What is YKR045C and why is it relevant to study?

YKR045C is a protein of unknown function in yeast that has been identified as a potential substrate of the SCF-Grr1 ubiquitin ligase complex. While bulk levels of YKR045C do not show significant turnover in cycloheximide chase experiments, post-translational modifications (likely phosphorylation) have been observed in grr1Δ cells . The protein shows a high-molecular-weight smear pattern in GRR1 cells that disappears over time, suggesting selective degradation of modified forms . Studying YKR045C may provide insights into cellular regulation mechanisms involving the ubiquitin-proteasome system, particularly in relation to cell cycle progression and protein quality control.

What validation approaches are essential before using a YKR045C antibody?

Validation of YKR045C antibodies should follow a multi-step approach to ensure specificity. First, perform Western blot analysis using wild-type yeast strains alongside YKR045C knockout strains to confirm absence of signal in knockout samples. Second, test antibody recognition patterns in both GRR1 and grr1Δ backgrounds, as these show distinct YKR045C migration patterns on SDS-PAGE . Third, utilize recombinant YKR045C protein as a positive control. Fourth, include appropriate negative controls such as secondary antibody-only samples. Finally, consider using orthogonal detection methods like mass spectrometry to validate antibody specificity . This comprehensive validation approach is crucial as poor antibody validation continues to be a major source of irreproducibility in research .

What are recommended applications for YKR045C antibodies?

Based on available research data, YKR045C antibodies are suitable for several experimental applications:

How should I design experiments to study YKR045C ubiquitination?

To effectively study YKR045C ubiquitination, implement a comprehensive experimental design that accounts for its unique characteristics. Begin with synchronized cell populations at different cell cycle stages, as YKR045C shows cell cycle-dependent modifications . Include both wild-type and grr1Δ strains to distinguish between SCF-Grr1-dependent and independent ubiquitination. Use proteasome inhibitors (MG132 in pdr5Δ yeast) to accumulate ubiquitinated species, and consider affinity purification with tandem ubiquitin-binding entities (TUBEs) to enrich for ubiquitinated proteins. When performing Western blot analysis, use gradient gels (4-12%) to clearly resolve the high-molecular-weight smear representing ubiquitinated YKR045C forms. Include controls for antibody specificity and consider dual detection of YKR045C and ubiquitin to confirm ubiquitination . This approach parallels successful strategies used with other SCF substrates and accommodates the unique stability characteristics of YKR045C.

What are optimal conditions for Western blotting detection of YKR045C?

For optimal Western blot detection of YKR045C, follow these methodological guidelines based on research with similar proteins. First, extract proteins using denaturing buffers containing phosphatase inhibitors to preserve modification states. Use fresh samples whenever possible, as freeze-thaw cycles may affect detection of post-translationally modified forms. Load 20-50 μg of total protein on gradient gels (4-12%) to effectively resolve both unmodified and high-molecular-weight forms. Transfer to PVDF membranes (rather than nitrocellulose) at lower voltage (30V) overnight for improved transfer of high-molecular-weight species. Block membranes with 5% BSA in TBST rather than milk, as milk proteins can interfere with phosphoprotein detection . Dilute primary antibodies in the same blocking buffer and incubate overnight at 4°C with gentle rocking. For detection of the phosphorylated form observed in grr1Δ strains, consider using Phos-tag gels to enhance separation of phosphorylated species . These optimizations will improve sensitivity and specificity for detecting both native and modified forms of YKR045C.

How can I detect transient interactions between YKR045C and SCF-Grr1 complex?

To detect the transient interactions between YKR045C and the SCF-Grr1 complex, employ ligase trapping technology as demonstrated in previous studies . This approach uses a fusion protein consisting of a ubiquitin-binding domain (UBA) and an F-box protein, which "traps" ubiquitinated substrates by preventing their release from the SCF complex. Specifically:

• Express a UBA-Grr1 fusion protein in yeast alongside 6xHis-ubiquitin

• Perform a two-step purification (Ni-NTA followed by immunoprecipitation)

• Analyze the pulled-down proteins by LC-MS/MS or Western blotting

• Include controls with unrelated F-box proteins to confirm specificity

This method has successfully identified YKR045C as a potential substrate in previous experiments, with spectral counts showing association with Grr1 (0.8 mean spectral count) . Alternatively, consider crosslinking approaches such as BioID or APEX proximity labeling to capture these interactions. For maximum sensitivity, synchronize cells in G1 or nocodazole and add proteasome inhibitors to stabilize the complex.

How can I distinguish between phosphorylated and ubiquitinated forms of YKR045C?

Distinguishing between phosphorylated and ubiquitinated forms of YKR045C requires a multi-faceted analytical approach. First, perform parallel Western blots with samples treated with λ-phosphatase to identify phosphorylation-dependent mobility shifts. The slightly reduced mobility form observed in grr1Δ cells is likely phosphorylated based on previous observations . Second, to confirm ubiquitination, immunoprecipitate YKR045C and probe with anti-ubiquitin antibodies, or conversely, purify ubiquitinated proteins using TUBEs and probe for YKR045C. Third, employ 2D gel electrophoresis (separating first by isoelectric point, then by molecular weight) to resolve differentially modified species. Fourth, for definitive identification, use mass spectrometry analysis of immunoprecipitated YKR045C to map both phosphorylation sites (look for +80 Da modifications) and ubiquitination sites (look for the characteristic GG dipeptide remnant after trypsin digestion). Finally, generate phospho-mutant constructs (S/T to A mutations) to determine if preventing phosphorylation affects subsequent ubiquitination patterns. This comprehensive approach has successfully distinguished modification states for other SCF substrates and should be equally applicable to YKR045C .

What approaches can determine if YKR045C degradation is cell cycle-dependent?

To determine if YKR045C degradation is cell cycle-dependent, implement these methodological approaches based on previous studies of cell cycle-regulated proteins. First, synchronize yeast cultures using α-factor (G1 arrest) or nocodazole (M-phase arrest) and collect samples at defined intervals following release. Perform cycloheximide chase experiments at each timepoint to measure protein stability through the cell cycle. Western blot analysis of these samples will reveal if degradation rates vary at different cell cycle stages . Second, use fluorescence microscopy with GFP-tagged YKR045C to visualize protein levels in single cells throughout the cell cycle, correlating protein intensity with cell morphology or with cell cycle markers. Third, employ a "degron-trapping" approach using cell cycle-specific degrons fused to a reporter protein alongside YKR045C to determine if both proteins are degraded with similar timing. Fourth, compare degradation patterns in wild-type vs. cell cycle mutants (e.g., cdc mutants arrested at specific points). Previous experiments have shown that YKR045C exhibits a modified form in both G1 and nocodazole-arrested cells in grr1Δ strains, suggesting potential regulation at multiple cell cycle stages .

How can I develop phospho-specific antibodies for YKR045C?

Developing phospho-specific antibodies for YKR045C requires a systematic approach to ensure specificity and functionality. First, perform computational analysis of the YKR045C sequence to identify probable phosphorylation sites using tools like NetPhos, focusing on serine, threonine, and tyrosine residues in consensus motifs recognized by known kinases. Second, confirm these sites experimentally through mass spectrometry analysis of immunoprecipitated YKR045C from grr1Δ cells, where the phosphorylated form is stabilized . Third, design phosphopeptide immunogens containing the identified phosphorylation sites with 7-10 flanking amino acids on each side. For each site, synthesize both phosphorylated and non-phosphorylated peptides for antibody validation. Fourth, conjugate these phosphopeptides to carrier proteins (like KLH) and immunize rabbits using a prolonged immunization schedule to generate high-affinity antibodies. Fifth, purify the antibodies using a two-step affinity chromatography process: first pass the serum through a column with the non-phosphorylated peptide to remove antibodies that recognize the non-phosphorylated epitope, then enrich phospho-specific antibodies using a phosphopeptide column. Finally, validate the antibodies using Western blots comparing samples treated with or without phosphatase and testing against phospho-site mutants of YKR045C .

Why does YKR045C show stable bulk levels despite evidence of ubiquitination?

The apparent paradox of YKR045C showing stable bulk levels despite evidence of ubiquitination can be explained through several mechanistic possibilities. First, YKR045C may undergo "selective degradation," where only specific post-translationally modified subpopulations (likely phosphorylated forms) are targeted for ubiquitination and subsequent degradation . This is supported by the observation that a high-molecular-weight smear (indicative of ubiquitinated species) disappears over time in cycloheximide chase experiments, while bulk protein levels remain stable . Second, ubiquitination of YKR045C might serve non-degradative functions such as altering protein localization, modifying activity, or regulating protein-protein interactions. Third, the protein may exist in distinct cellular pools with different half-lives, with only a small fraction being actively turned over at any given time. Fourth, the degradation might be highly context-dependent, occurring only during specific cellular states or stress conditions not captured in standard stability assays. This phenomenon is not unique to YKR045C; several other proteins identified in the same ligase trapping experiment (Met2, Npl4, and Sbe2) also showed discrepancies between steady-state levels and apparent stability in cycloheximide chase assays .

How should I interpret contradictory results between different YKR045C antibody lots?

When faced with contradictory results between different YKR045C antibody lots, implement a systematic troubleshooting approach based on antibody validation principles. First, perform side-by-side validation of all antibody lots using identical positive controls (recombinant YKR045C) and negative controls (YKR045C knockout samples). Second, test each lot against multiple sample types to determine if the discrepancies are sample-specific or antibody-specific. Third, evaluate epitope accessibility by testing different sample preparation methods, as some antibody lots may recognize epitopes that are masked under certain conditions. Fourth, assess lot-to-lot variation in specificity using peptide competition assays, where pre-incubation with the immunizing peptide should abolish specific binding . Fifth, consider that different antibody lots might preferentially recognize distinct post-translational modifications or conformational states of YKR045C, especially given its documented phosphorylation and ubiquitination . Finally, maintain detailed records of antibody performance across lots, including images of original blots, to track patterns in variability. This systematic approach follows best practices for ensuring antibody reproducibility in research settings and specifically addresses the known modifications of YKR045C that could affect epitope recognition.

What explains the differential detection of YKR045C in wild-type versus grr1Δ strains?

The differential detection of YKR045C in wild-type versus grr1Δ strains observed in previous studies can be explained by several molecular mechanisms. In grr1Δ cells, YKR045C displays a distinct form with slightly reduced mobility that is absent in wild-type cells, likely representing a phosphorylated species . This pattern suggests that in wild-type cells, the SCF-Grr1 complex specifically targets the phosphorylated form of YKR045C for ubiquitination and subsequent degradation, consistent with the canonical phospho-degron recognition model of many F-box proteins. The rapid turnover of this phosphorylated form in wild-type cells explains its absence in steady-state analysis. Additionally, the high-molecular-weight ubiquitinated smear observed exclusively in wild-type cells further supports this model, as these ubiquitinated species are not formed in the absence of Grr1 . Interestingly, while the bulk levels of YKR045C remain stable, the specific degradation of post-translationally modified forms represents a form of "qualitative regulation" rather than "quantitative regulation." This mechanism allows cells to modulate the functional pool of YKR045C without affecting the total protein abundance, a regulatory strategy observed with other SCF substrates identified in the same study .

How can single-cell approaches improve YKR045C functional studies?

Single-cell approaches offer transformative potential for YKR045C functional studies by revealing heterogeneity masked in population-level analyses. Implement single-cell RNA-seq to correlate YKR045C expression with specific transcriptional programs across individual cells, potentially revealing functional associations not apparent in bulk analysis. Combine this with single-cell proteomics techniques that can measure YKR045C protein levels alongside potential interacting partners. For visualization, develop a split-fluorescent protein system where YKR045C is fused to one fragment and candidate interactors to complementary fragments, allowing real-time monitoring of protein-protein interactions in living cells. Additionally, CRISPR-based lineage tracing combined with YKR045C fluorescent tagging can reveal how cellular inheritance of YKR045C affects daughter cell phenotypes. These approaches parallel recent advances in antibody-based detection technologies where genotype-phenotype linkage has significantly improved detection sensitivity and specificity . Given that YKR045C shows post-translational modifications in a cell cycle-dependent manner , single-cell methods are particularly valuable for capturing this temporal regulation that might be obscured in population averages.

What are emerging methods for studying YKR045C's role in protein quality control?

Emerging methods for studying YKR045C's potential role in protein quality control leverage cutting-edge technologies developed for similar cellular pathways. Implement proximity-labeling approaches like BioID or TurboID, where YKR045C is fused to a promiscuous biotin ligase to identify neighboring proteins in living cells. This can reveal associations with quality control machinery that may be too transient for traditional co-immunoprecipitation. Develop a split-ubiquitin yeast two-hybrid system specifically optimized for membrane and compartment-associated interactions to map YKR045C's functional interactome. For structural insights, consider in-cell NMR spectroscopy to observe conformational changes of YKR045C under different cellular conditions. Additionally, CRISPR screens focused on synthetic interactions with YKR045C can uncover functional redundancies and compensatory pathways. Finally, integrate these approaches with systems-level analyses comparing cells with wild-type, deleted, or modified YKR045C under various stress conditions to deduce its functional role. The observation that YKR045C exhibits ubiquitination patterns dependent on the SCF-Grr1 complex suggests potential involvement in regulated protein turnover pathways , making these approaches particularly relevant for uncovering its function in protein quality control.

How can integrated multi-omics improve our understanding of YKR045C function?

Integrated multi-omics approaches provide powerful frameworks for comprehensively elucidating YKR045C function by connecting different layers of cellular regulation. Implement parallel analyses of transcriptomics, proteomics, phosphoproteomics, and ubiquitylomics in isogenic strains with wild-type or deleted YKR045C. This multi-layered approach can reveal how YKR045C influences gene expression patterns, protein abundance, and post-translational modification networks. Specifically, phosphoproteomic analysis may identify substrates affected by YKR045C activity, while ubiquitylomics can determine if its deletion alters global ubiquitination patterns. Complement these approaches with metabolomics to detect potential metabolic functions, and interactomics using affinity purification-mass spectrometry to map interaction partners across different cellular conditions. For temporal dynamics, perform time-course analyses following cellular perturbations such as stress or cell cycle synchronization, as YKR045C shows differential modification patterns in G1 versus M-phase . Finally, employ machine learning algorithms to integrate these diverse datasets and predict functional relationships and regulatory networks involving YKR045C. This comprehensive approach parallels recent advances in antibody characterization where multiple complementary methods have improved functional understanding of poorly characterized proteins .